Treatment outcomes of patients with stage <scp>III non–small cell lung cancer</scp> and interstitial lung diseases receiving intensity‐modulated radiation therapy: A single‐center experience of 85 cases-Reference-Cited by-同舟云学术

Treatment outcomes of patients with stage III non–small cell lung cancer and interstitial lung diseases receiving intensity‐modulated radiation therapy: A single‐center experience of 85 cases

Published:2022-04-22 Issue:11 Volume:13 Page:1583-1591
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Wu Linfang¹^ORCID,Zhao Shijun²,Huang Hui³^ORCID,Wang Wenqing¹,Zhang Tao¹,Zhou Zongmei¹^ORCID,Feng Qinfu¹^ORCID,Liang Jun¹,Xiao Zefen¹,Hui Zhouguang¹^ORCID,Lv Jima¹,Bi Nan¹,Wang Luhua⁴^ORCID

Affiliation:

1. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Respiratory Medicine Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

4. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen China

Funder

Sanming Project of Medicine in Shenzhen

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14418

Reference29 articles.

1. Spectrum of Fibrotic Lung Diseases

2. A Primer on Interstitial Lung Disease and Thoracic Radiation

3. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer